Pretax income is the income that a company earns before paying income taxes. Journey Medical's pretax income for the
three
months ended in Mar. 2024 was $-10.44 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.94 Mil.
Journey Medical's pretax margin was -80.14%.
During the past 5 years, Journey Medical's highest Pretax Margin was 16.06%. The lowest was -67.10%. And the median was -4.59%.
Journey Medical Pre-Tax Income Historical Data
The historical data trend for Journey Medical's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Journey Medical's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Journey Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Journey Medical's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Journey Medical's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Journey Medical's Pre-Tax Income falls into.
Journey Medical Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Journey Medical's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Journey Medical (NAS:DERM) Pre-Tax Income Explanation
Journey Medical's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 5 years, Journey Medical's highest Pretax Margin was 16.06%. The lowest was -67.10%. And the median was -4.59%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Journey Medical Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Journey Medical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Journey Medical (Journey Medical) Business Description
Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DERM has been successfully added to your 